Omnatax in acute urinary tract infection. A clinical study.
25 patients of acute urinary tract infection with E. coli received Omnatax, 1 gm. b.d. 80% patients had bacteriologic cure on second day and 96% on fourth day of treatment. When assessed in light of the disappearance or decrease in pyuria and bacteriuria, 72% patients showed excellent response and 28% moderate response at the end of treatment. Clinical cure was achieved in 84% of patients. Mean number of days required for the patients to become symptom-free was 3.5 and mean time to achieve complete bacterial elimination was 1.96 days.
Choudhury
A
A
D000208:Acute Disease; D000328:Adult; D002439:Cefotaxime / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002439:Cefotaxime